These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 890495)

  • 21. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural and neurochemical studies on the striatonigral GABA pathway [proceedings].
    Cross AJ; Waddington JL
    Br J Pharmacol; 1979 Jul; 66(3):477P-478P. PubMed ID: 526755
    [No Abstract]   [Full Text] [Related]  

  • 23. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.
    Feltz P
    Appl Neurophysiol; 1979; 42(1-2):47-50. PubMed ID: 222207
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of GABA in the substantia nigra.
    James TA; Starr MS
    Nature; 1978 Sep; 275(5677):229-30. PubMed ID: 692697
    [No Abstract]   [Full Text] [Related]  

  • 26. Innervation of the substantia nigra.
    Misgeld U
    Cell Tissue Res; 2004 Oct; 318(1):107-14. PubMed ID: 15338269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gabaergic regulation of nigrostriatal neurons: coupling of benzodiazepine and GABA receptors.
    Wood PL; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):471-4. PubMed ID: 6298891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis.
    Starr MS; Summerhayes M; Kilpatrick IC
    Neuroscience; 1983 Mar; 8(3):547-59. PubMed ID: 6856085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 30. The turnover rate of gamma-aminobutyric acid in the substantia nigra following electrical stimulation or lesioning of the strionigral pathways.
    Mao CC; Peralta E; Morini F; Costa E
    Brain Res; 1978 Oct; 155(1):147-52. PubMed ID: 688008
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo measurement of [3H]GABA release: an approach to the study of the regulation of GABA-containing neurons in the basal ganglia and associated structures in the cat and the rat.
    Besson MJ; Kemel ML; Gauchy C; Girault JA; Spampinato U; Lantin N; Desban M; Glowinski J
    Ann N Y Acad Sci; 1986; 473():475-88. PubMed ID: 3541740
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 33. Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
    Waddington JL
    Br J Pharmacol; 1978 Jun; 63(2):384P. PubMed ID: 566600
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relation between GABAergic and dopaminergic neurons in the basal ganglia].
    Kemel ML; Gauchy C; Girault JA; Besson JM; Glowinski J
    Encephale; 1987 Jul; 13 Spec No():169-71. PubMed ID: 3319524
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity-dependent changes in substantia nigra gamma-aminobutyric acid.
    Swift RM; Hoffmann PC; Heller A
    Brain Res; 1978 Nov; 156(1):181-6. PubMed ID: 308835
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physiology and pharmacology of extrapyramidal tract].
    Yoshida M; Mizuno Y
    Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 40. Amphetamine- and stress-induced turning after nigral transplants in neonatally dopamine-depleted rats.
    Carder RK; Snyder-Keller AM; Lund RD
    Brain Res; 1987 Jun; 430(2):315-8. PubMed ID: 2886195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.